PRELUDE CAPITAL MANAGEMENT, LLC - ARATANA THERAPEUTICS INC ownership

ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 102 filers reported holding ARATANA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of ARATANA THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$95,000
+1087.5%
18,378
+733.5%
0.01%
Q1 2019$8,000
-50.0%
2,205
-16.6%
0.00%
-100.0%
Q4 2018$16,000
+23.1%
2,645
+22.8%
0.00%0.0%
Q3 2018$13,000
+18.2%
2,154
-18.3%
0.00%0.0%
Q2 2018$11,000
+10.0%
2,638
+20.5%
0.00%0.0%
Q1 2018$10,000
+66.7%
2,190
+108.6%
0.00%
Q4 2017$6,000
-64.7%
1,050
-41.7%
0.00%
-100.0%
Q3 2016$17,000
-85.6%
1,800
-91.5%
0.00%
-88.9%
Q4 2015$118,000
-57.2%
21,177
-35.0%
0.02%
-55.0%
Q3 2015$276,000
+63.3%
32,574
+190.8%
0.04%
+66.7%
Q2 2015$169,000
+27.1%
11,200
+34.9%
0.02%
+33.3%
Q1 2015$133,000
-7.0%
8,300
+3.8%
0.02%
-14.3%
Q4 2014$143,000
+78.8%
8,0000.0%0.02%
+90.9%
Q3 2014$80,000
-36.0%
8,0000.0%0.01%
-35.3%
Q2 2014$125,000
-15.5%
8,0000.0%0.02%
-15.0%
Q1 2014$148,000
-3.3%
8,0000.0%0.02%
-20.0%
Q4 2013$153,000
+16.8%
8,0000.0%0.02%
+19.0%
Q3 2013$131,0008,0000.02%
Other shareholders
ARATANA THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Engaged Capital LLC 3,487,149$21,376,0003.96%
Broadfin Capital, LLC 4,083,135$25,030,0003.29%
MPM ASSET MANAGEMENT LLC 250,000$1,533,0001.30%
GENERAL AMERICAN INVESTORS CO INC 1,599,365$9,804,0001.03%
Grandeur Peak Global Advisors, LLC 821,038$5,033,0000.65%
CADENCE CAPITAL MANAGEMENT LLC 307,294$1,884,0000.19%
Redmond Asset Management, LLC 60,176$369,0000.18%
Alambic Investment Management, L.P. 65,000$398,0000.17%
MENTA CAPITAL LLC 39,562$243,0000.09%
Campbell & CO Investment Adviser LLC 12,990$88,0000.09%
View complete list of ARATANA THERAPEUTICS INC shareholders